Recs

3

Super Seed Swap

Instead of continuing to fight each other in court, agribusiness companies Syngenta (NYSE: SYT  ) and Monsanto (NYSE: MON  ) called a truce for their never-ending patent disputes last week.

In the settlement, Monsanto gets a royalty-bearing license to Syngenta's technology to make crops tolerant to dicamba, an herbicide that kills weeds but not resistant crops. Syngenta gets a license to Monsanto's Roundup-tolerant and insect-protected corn borer traits.

Without knowing the royalty rates for the licenses, it's a little hard to know which company got the better deal. It's worth noting that both companies agreed to drop lawsuits against each other as part of the deal. It looks to me like Monsanto had more to lose with the lawsuits, because Syngenta was making antitrust claims against Monsanto. If Monsanto had lost, presumably that would have put other licensing deals in jeopardy.

The future of crops is multiple traits -- drought tolerance, herbicide resistance, and higher yield, for instance -- combined in one plant. We're already seeing the start of the stacked-trait era with products like Monsanto's SmartStax Corn. The crop, which should launch in 2010, will have eight genetic modifications to improve its yield.

It's interesting how the companies are going about combining the traits that their competitors own. Monsanto has a deal with BASF to discover new traits, and Syngenta has a similar deal with DuPont's (NYSE: DD  ) Pioneer. Now all we need is a deal between DuPont and BASF and the circle will be complete.

If the companies continue this, it seems possible that eventually, all the seed manufacturers will be selling the same super seeds with traits developed by all the different companies. In the meantime, the deal between Monsanto and Syngenta should help both companies compete against their rivals.

For more Foolishness:

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Motley Fool Rule Breakers is always on the hunt for cutting-edge picks. See all of our latest discoveries with a free 30-day trial. 

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. The Fool has a disclosure policy


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 652613, ~/Articles/ArticleHandler.aspx, 2/14/2012 10:55:03 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,830.78 -43.26 -0.34%
S&P 500 1,345.85 -5.92 -0.44%
NASD 2,920.21 -11.18 -0.38%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/14/2012 10:25 AM
SYT $63.27 Down -0.58 -0.91%
Syngenta CAPS Rating: ****
MON $77.28 Down -0.65 -0.83%
Monsanto Company CAPS Rating: ****
DD $49.99 Down -0.61 -1.21%
E.I. du Pont de Ne… CAPS Rating: ****

Advertisement